How GE Healthcare Leads the Development of Accurate ECG Diagnosis in China

How GE Healthcare Leads the Development of Accurate ECG Diagnosis in China

In the field of diagnosis and treatment of cardiovascular diseases, ECG is an important means of diagnosing cardiovascular diseases. Since the development of electrocardiogram, traditional and single products have been unable to meet the diagnosis and treatment needs of modern medicine. Especially after the new crown epidemic, how to use the advantages of network information to meet the needs of one-to-many diagnosis and treatment, and enhance the ability of remote diagnosis and treatment has become an urgent problem to be solved in the industry.

Recently, GE Healthcare released two new-generation high-end digital ECG products, which have entered the industry's field of vision as pioneers in ECG intelligent diagnosis.

At present, in the process of clinical electrocardiogram examination, we are faced with various problems such as complex operation of equipment, insufficient acquisition accuracy, diverse ECG data formats, insufficient measurement matrix parameters, and unclear display of pacing signals. These problems not only make the field of ECG The limited development of research has created great obstacles to the statistics of scientific research data and the publication of high-level papers, and has also had a great impact on the accurate reading of ECG by grassroots doctors.

Therefore, it is very important to establish a standard ECG network management system to help clinicians improve diagnosis and treatment performance through high-precision data collection and digital means, and to buy precious time for patients.

GE Healthcare has just released two new high-end digital ECG products, namely MAC 5 new generation 12+1 ECG analyzer with ACS intelligent diagnosis function, and MUSE NX new generation ECG intelligent diagnosis management system equipped with new algorithms.